Department of General Paediatrics and Paediatric Infectious Diseases, Necker-Enfants Malades University Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), Université de Paris, 149 rue de Sèvres, 75015 Paris, France.
Institut Pasteur, Biodiversity and Epidemiology of Bacterial Pathogens, Paris, France.
BMJ. 2020 Jun 3;369:m2094. doi: 10.1136/bmj.m2094.
To describe the characteristics of children and adolescents affected by an outbreak of Kawasaki-like multisystem inflammatory syndrome and to evaluate a potential temporal association with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Prospective observational study.
General paediatric department of a university hospital in Paris, France.
21 children and adolescents (aged ≤18 years) with features of Kawasaki disease who were admitted to hospital between 27 April and 11 May 2020 and followed up until discharge by 15 May 2020.
The primary outcomes were clinical and biological data, imaging and echocardiographic findings, treatment, and outcomes. Nasopharyngeal swabs were prospectively tested for SARS-CoV-2 using reverse transcription-polymerase chain reaction (RT-PCR) and blood samples were tested for IgG antibodies to the virus.
21 children and adolescents (median age 7.9 (range 3.7-16.6) years) were admitted with features of Kawasaki disease over a 15 day period, with 12 (57%) of African ancestry. 12 (57%) presented with Kawasaki disease shock syndrome and 16 (76%) with myocarditis. 17 (81%) required intensive care support. All 21 patients had noticeable gastrointestinal symptoms during the early stage of illness and high levels of inflammatory markers. 19 (90%) had evidence of recent SARS-CoV-2 infection (positive RT-PCR result in 8/21, positive IgG antibody detection in 19/21). All 21 patients received intravenous immunoglobulin and 10 (48%) also received corticosteroids. The clinical outcome was favourable in all patients. Moderate coronary artery dilations were detected in 5 (24%) of the patients during hospital stay. By 15 May 2020, after 8 (5-17) days of hospital stay, all patients were discharged home.
The ongoing outbreak of Kawasaki-like multisystem inflammatory syndrome among children and adolescents in the Paris area might be related to SARS-CoV-2. In this study an unusually high proportion of the affected children and adolescents had gastrointestinal symptoms, Kawasaki disease shock syndrome, and were of African ancestry.
描述爆发性川崎病样多系统炎症综合征患儿和青少年的特征,并评估其与严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染的潜在时间关联。
前瞻性观察性研究。
法国巴黎一所大学医院的普通儿科病房。
2020 年 4 月 27 日至 5 月 11 日期间因川崎病特征而住院的 21 名儿童和青少年(年龄≤18 岁),并随访至 2020 年 5 月 15 日出院。
主要结局为临床和生物学数据、影像学和超声心动图检查结果、治疗和结局。通过逆转录聚合酶链反应(RT-PCR)对鼻咽拭子进行前瞻性 SARS-CoV-2 检测,检测病毒 IgG 抗体。
在 15 天内,21 名儿童和青少年(中位年龄 7.9(范围 3.7-16.6)岁)因川崎病特征而住院,其中 12 名(57%)为非裔。12 名(57%)出现川崎病休克综合征,16 名(76%)出现心肌炎。17 名(81%)需要重症监护支持。所有 21 名患者在疾病早期均有明显的胃肠道症状和高水平的炎症标志物。19 名(90%)有近期 SARS-CoV-2 感染的证据(21 名中有 8 名 RT-PCR 阳性结果,21 名中有 19 名 IgG 抗体检测阳性)。所有 21 名患者均接受静脉注射免疫球蛋白治疗,10 名(48%)还接受皮质类固醇治疗。所有患者的临床结局均良好。在住院期间,5 名(24%)患者检测到中度冠状动脉扩张。截至 2020 年 5 月 15 日,住院 8(5-17)天后,所有患者均出院回家。
巴黎地区儿童和青少年中爆发的川崎病样多系统炎症综合征可能与 SARS-CoV-2 有关。在这项研究中,受影响的儿童和青少年中异常高比例的患者有胃肠道症状、川崎病休克综合征和非裔血统。